A drug commonly used for Parkinson’s disease, called pramipexole, has shown strong results in helping people with depression that hasn’t improved with standard treatments. This new finding comes from ...

The study examines the long-term effects of fluoxetine in rat brains when administered at a young age, lead to a series of ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

A new study published in Psychiatry Research provides evidence that the longer people take antidepressants, the more likely ...

Wondering what’s the strongest weight loss prescription pill? If you came here expecting a one-size-fits-all answer, we have bad news. The term “strength” is extremely subjective when ...

For many patients, it’s clearly worth it to start on antidepressants. There’s strong evidence that antidepressants are more effective than a placebo, especially for short-term use.

There’s no clear-cut answer on when it’s time to stop your antidepressants, but a few signs can help you decide if you're ready to start tapering.

And the research, undertaken by a European research team, points to a strong reason to develop drugs that modify galanin functioning as a new class of antidepressant drug. Galanin is a neuropeptide (a ...

Millions of Americans take antidepressants to help manage everything from depression and anxiety to post-traumatic stress disorder. Now, the Trump administration has announced that these drugs ...

A specific class of antidepressant medications -- selective serotonin reuptake inhibitors -- actually might speed up brain decline among some dementia patients, a new Swedish study suggests.

Antidepressants taken by millions of patients could accelerate memory loss in some patients, a large study suggests. Swedish scientists found dementia patients taking selective serotonin reuptake ...

When antidepressants are introduced, they increase serotonin levels, improving mood. When the medication is stopped, the brain must recalibrate its own production of these neurotransmitters, which ...